Results 241 to 250 of about 98,309 (302)

Treatment approaches to patients with multiple sclerosis and coexisting psoriasis - A longitudinal multicenter observational cohort study. [PDF]

Neurotherapeutics
Brummer T, Räuber S, Jakob J, Willison AG, Schraad M, Protopapa M, Fleischer MI, Boeckers JM, Ruck T, Meuth SG, Zipp F, Fleischer V, Bittner S.   +12 more
europepmc   +1 more source

Acute Myeloid Leukemia With Florid Plasmacytoid Dendritic Cell Expansion and Aberrant Expression of CD19

International Journal of Laboratory Hematology, EarlyView.
Afshin Shameli, Russell K. Dorer
wiley   +1 more source

Zirconia, titanium, and polyetheretherketone implant abutments show equal long‐term clinical success—A systematic review and network meta‐analysis

Periodontology 2000, EarlyView.
Abstract Hundreds of millions of people have one or more missing teeth. Consequently, a substantial number of patients undergo implant therapy each year. However, technical complications and soft tissue inflammation associated with the implant abutment or the type of restoration can lead to bone loss and, ultimately, implant failure.
Yasir Nabeel Al‐Mohammad, Caroline Kelly, Petrana Martinekova, Alexander Schulze Wenning, Szilvia Kiss‐Dala, Noémi Gede, Beáta Kerémi, Zsolt Németh, Péter Hermann, László Márk Czumbel, Krisztina Mikulás, Péter Hegyi, Anton Sculean, Gábor Varga   +13 more
wiley   +1 more source

Classic Hairy Cell Leukemia and Related Disorders: An Updated Review of Molecular Features and Personalized Therapies. [PDF]

J Pers Med
Shah PV, Ng A, Shih A, Pham T, Wang J, Khalili H, Chiang CH, Singhal A, Rosenberg A, Ko S, Wallin M, Gladstone DE.   +11 more
europepmc   +1 more source

Toxoplasmosis Beyond Transplantation: Diagnostic and Prevention Challenges in a Patient Receiving Targeted Immunomodulators

Transplant Infectious Disease, EarlyView.
ABSTRACT Toxoplasmosis has long been recognized as a serious complication in immunocompromised host, particularly those with advanced HIV/AIDS, hematopoietic stem‐cell transplantation (HSCT), solid‐organ transplant (SOT), and hematological malignancies. The rapid expansion of targeted immunomodulators, including chimeric antigen receptor T‐cell (CAR‐T)
Joy Mouanes‐Abelin, Christelle Pomares, José G. Montoya, Morgane Pondrom, Lucille DE MARIA, Andrea J. Zimmer, Carlos A. Gomez   +6 more
wiley   +1 more source

Comparative effectiveness of anti-CD20 therapies and S1P receptor modulators in late-onset multiple sclerosis: real-world evidence from the MSBase registry. [PDF]

Ther Adv Neurol Disord
Surcinelli A, Kalincik T, Roos I, D'Amico E, Lechner-Scott J, Ozakbas S, Hradilek P, Horáková D, Vachova M, Panzera I, Ruzza S, Piscaglia MG, Gerlach O, Meca-Lallana JE, Valero-López G, Kermode AG, Fabis-Pedrini MJ, Prevost J, Ampapa R, Hodgkinson S, Grand'Maison F, Khoury SJ, John NA, Peterka M, Houskova J, Recmanova E, Rous Z, Shaygannejad V, Alroughani R, Kuhle J, Jakob GB, Grammond P, Patti F, Van der Walt A, Butzkueven H, Foschi M.   +35 more
europepmc   +1 more source

CD20-Targeted α-Radionuclides Synergize with Immune Checkpoint Inhibition to Treat Murine Lymphoma. [PDF]

J Nucl Med
O'Steen S, Lee SY, Comstock ML, Kehret AR, Lin Y, Hamlin DK, Dexter SL, Hippe DS, Gooley TA, Wilbur DS, Li Y, Walter RB, Till B, Orozco JJ, Green DJ.   +14 more
europepmc   +1 more source

Impact of heme on the therapeutic efficacy of anti-CD20 antibodies. [PDF]

J Biol Chem
Marey-Jarossay A, Tavares A, Lacombe RV, Delcourt H, Lecerf M, Cruz-Aguirre AS, Lassouani TH, Gilardin L, Tareste D, Kaveri SV, Lacroix-Desmazes S, Siberil S, Teillaud JL, Dimitrov JD.   +13 more
europepmc   +1 more source

Polymorphic EBV-positive post-transplant lymphoproliferative disorder of the colon mimicking EBV-positive mucocutaneous ulcer: a case report. [PDF]

J Hematop
Wallace M, Dessain A, Mikkilineni S, Hammer RD.   +3 more
europepmc   +1 more source

Reevaluating the nature of thymic lipofibroadenoma: A case report with hamartomatous features and a literature review. [PDF]

Medicine (Baltimore)
Zhou N, Hu S, Chen L, Wu H, Wang F, Wang F.   +5 more
europepmc   +1 more source